Comparing stenting vs. drug-coated balloon for heart artery splits
Part of Heart & circulation clinical trials.
This trial compares two ways to treat blockages in a heart artery split (bifurcation) that are not in the left main artery. It tests whether a drug-coated balloon works as well as a stent for the side branch of the split.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blockage in a non-left main artery split (Medina type 1/1/1, 1/0/1, or 0/1/1).
- The blockage causes symptoms like chest pain or has been shown to affect blood flow by tests.
- The side branch is at least 50% narrowed, is at least 2.5mm wide, and is at least 73mm long.
- You are at least 18 years old.
- You have not had a recent large heart attack (STEMI within 48 hours).
- You are not in cardiogenic shock and do not have a chronic total blockage in the artery being treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to treat blockages where a heart artery splits into two branches: using special balloons that release medication versus placing stents (small metal tubes). The goal is to find the safest and most effective approach for patients with stable chest pain and proven heart blood-flow problems.
This trial compares two ways to open a specific type of heart blockage that involves both a main artery and a side branch. It tests whether using a drug-coated balloon (“hybrid strategy”) works as well as using a planned two-stent approach (“stepwise provisional strategy”).
This trial compares two ways of placing a stent at the point where the main left artery splits into two branches. It is for people who have a blockage in the very beginning of one of those branches, and it uses advanced drug-eluting stents to see which method works better.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial compares two techniques for placing stents in the tricky area where a coronary artery splits into two branches (a bifurcation). The goal is to see which method leads to better blood flow and fewer complications for people with blockages there.
Hear when a new Coronary Bifurcation Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.